Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at :

NCT ID NCT04430192
Title Dosimetry, Safety and Potential Benefit of 177Lu-PSMA-617 Prior to Prostatectomy (LuTectomy)
Recruitment Active, not recruiting
Gender male
Phase Phase Ib/II
Variant Requirements No
Sponsors Peter MacCallum Cancer Centre, Australia

prostate adenocarcinoma


lutetium Lu 177 vipivotide tetraxetan

Age Groups: senior | adult
Covered Countries

No variant requirements are available.